Role of basal inflammatory status as a predictor of survival in bevacizumab-treated advanced non-small cell lung cancer (NSCLC) patients.

被引:0
|
作者
Botta, C.
Guglielmo, A.
Bestoso, E.
Apollinari, S.
Licchetta, A.
Blardi, P.
Tassone, P.
Chiriaco, G.
Barbieri, V.
Mantovani, G.
Tagliaferri, P.
Correale, P.
机构
[1] Siena Univ Hosp, Ist Toscano Tumori, Med Oncol Unit, Dept Oncol, Siena, Italy
[2] Sect Med Oncol, Siena, Italy
[3] Siena Univ Hosp, Dept Clin Pharmacol, Siena, Italy
[4] Univ Catanzaro, Sch Med, Sect Med Oncol, Catanzaro, Italy
[5] Magna Graecia Univ Catanzaro, Med Oncol Unit, Catanzaro, Italy
[6] Tommaso Campanella Canc Ctr, Catanzaro, Italy
[7] Univ Cagliari, Dept Med Oncol, Cagliari, Italy
[8] Siena Univ Hosp, Dept Oncol, Med Oncol Unit, Siena, Italy
关键词
D O I
10.1200/jco.2011.29.15_suppl.7582
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7582
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Quality of life and survival in patients receiving chemotherapy for advanced non-small cell lung cancer (NSCLC)
    St-Pierre, D. M.
    Kreisman, H.
    Kasymjanova, G.
    Agulnik, J. S.
    Swanson, T.
    Pepe, C.
    Lajeunesse, L.
    Gagne, S.
    Dajczman, E.
    Pereira, L.
    Small, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] The effect of depression on survival in patients with newly diagnosed advanced non-small cell lung cancer (NSCLC).
    Temel, J. S.
    Jackson, V. A.
    Billings, A.
    Prigerson, H. G.
    Fidias, P.
    Lynch, T. J., Jr.
    Pirl, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 470S - 470S
  • [33] Marital Status Is an Independent Predictor of Survival for Patients Undergoing Definitive Chemoradiation for Stage III Non-small Cell Lung Cancer (NSCLC)
    Nichols, E. M.
    Liriano, M.
    Morris, C. G.
    Burrows, W.
    Battafarano, R.
    Garofalo, M.
    Turner, M.
    Suntharalingam, M.
    Edelman, M. J.
    Feigenberg, S. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S566 - S567
  • [34] Marital Status Is An Independent Predictor Of Survival For Patients Undergoing Definitive Chemoradiation For Stage Iii Non-small Cell Lung Cancer (nsclc)
    Nichols, E. M.
    Liriano, M.
    Morris, C. G.
    Burrows, W.
    Battafarano, R.
    Garofalo, M.
    Turner, M.
    Suntharalingam, M.
    Edelman, M. J.
    Feigenberg, S. J.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S274 - S274
  • [35] ERLOTINIB AND BEXAROTENE FOR PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Dragnev, K. H.
    Seltzer, M.
    Rigas, J. R.
    DiSalvo, W. M.
    Simeone, S.
    Johnstone, D.
    Nugent, W.
    Waxman, S.
    Dmitrovsky, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 102 - 102
  • [36] Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib
    Fiala, O.
    Pesek, M.
    Finek, J.
    Racek, J.
    Minarik, M.
    Benesova, L.
    Bortlicek, Z.
    Sorejs, O.
    Kucera, R.
    Topolcan, O.
    NEOPLASMA, 2016, 63 (03) : 471 - 476
  • [37] Can nutritional status predict survival in patients with advanced non-small cell lung cancer?
    Lee, Sookyung
    Seo, Youngkwang
    Eo, Wankyu
    Kim, Sehyun
    Shim, Bumsang
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] Pharmacokinetics of Cemiplimab in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Papachristos, A.
    Masinde, S.
    Davis, J. D.
    Gullo, G.
    Rietschel, P.
    Paccaly, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S308 - S309
  • [39] SURVIVAL OF PATIENTS WITH BRAIN METASTASES AND NON-SMALL CELL LUNG CANCER (NSCLC)
    Randhawa, J. K.
    Patel, S. P.
    Stokes, T. C.
    THORAX, 2009, 64 : A148 - A148
  • [40] Redox Status in Patients with non-small Cell Lung Cancer in Advanced Stages Treated with Polychemotherapy
    Riveron Forment, Gretel
    Fernandez Garcia, Sergio
    Pandolfi Blanco, Anamarys
    Contreras Roura, Jiovanna
    Lopez Izada, Yanet
    FINLAY, 2022, 12 (02): : 221 - 227